lobbying_activities: 2860369
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2860369 | e5ebb4fb-4a03-4373-8d02-8553452a42dd | Q3 | SMITHBUCKLIN CORPORATION | 35684 | ASTCT | 2022 | third_quarter | MMM | CMS coding and billing clarity for CAR-T therapies; CMS engagement and follow up on FY2021 new MS-DRG for CAR-T Therapies Covid funding, Patient Care Episode, Financial Toxicity | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-10-04T15:18:57-04:00 |